Repair and Regeneration of Peripheral Nerve Fibrosis

Ghosh, Nilabh. Repair and Regeneration of Peripheral Nerve Fibrosis. 2021, Doctoral Thesis, University of Basel, Faculty of Medicine.

Available under License CC BY (Attribution).


Official URL: https://edoc.unibas.ch/89806/

Downloads: Statistics Overview


Twenty million Americans suffer from peripheral nerve injury (PNI) and is undoubtedly one of the major unmet medical needs. Approximately $150 billion is spent annually in the United States for Nerve Injuries. Moreover, 50,000 cases of PNI repairs are performed annually in the United States with even less than 42% experiencing satisfactory sensory recovery. Despite extensive medical research, there aren’t any approved small molecule antifibrotic treatment pertaining to nerve injuries. Peripheral nerve fibrosis (PNF) associated with chronic inflammation, perineural adhesions and scarring are often reported in patients with nerve injury. Surgical interventions including external neurolysis is the common available option. Unfortunately, postsurgical adhesions and fibrosis, often lead to aberrated wound healing and impairment of nerve functions. Though, various treatment strategies have been tried including use
of grafts, biomaterials, no treatment modality seems to be promising as of now.
The aim of this study was to investigate the effects of L-Alanine-L-Glutamine (L-Ala-L-Gln) and Pirfenidone (PFD) on hypoxic and TGF-ß1 stimulated fibroblasts and their ability to induce anti-fibrotic phenotype. Rat perineurial derived fibroblasts were exposed to hypoxic conditions or externally activated by TGF-ß1 and expression of hypoxic and pro-fibrotic markers were assessed following treatment with L-Ala-L-Gln (0-100mM) or with PFD (0-0.25 mg/ml). PFD was found to act through targeted downregulation of the TGF-ß pathway and significantly reduced pro-fibrotic and celladhesion inducing factors at the protein and RNA level. In rat perineurial derived fibroblasts, L-Ala-L-Gln and PFD modulated several pro-fibrotic factors and associated
pathways to induce an anti-fibrotic phenotype. In conclusion, our results showed that L-Ala-L-Gln and PFD suppressed fibrotic phenotype and might prove to be effective anti-fibrotic agents for neural fibrosis. These promising results will lead to identification of a non-invasive biomarker for the assessment of neural fibrosis. These results can easily be translated into the clinical settings and we expect our discoveries to assist
clinicians to identify a novel therapeutic strategy for neural fibrosis and support invasive surgical applications.
Advisors:Guzman, Raphael and Kalbermatten, Daniel F. and Kelly, Michael
Faculties and Departments:03 Faculty of Medicine > Bereich Operative Fächer (Klinik) > Kopfbereich > Neurochirurgie (Guzman)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Operative Fächer (Klinik) > Kopfbereich > Neurochirurgie (Guzman)
UniBasel Contributors:Guzman, Raphael and Kalbermatten, Daniel F.
Item Type:Thesis
Thesis Subtype:Doctoral Thesis
Thesis no:14848
Thesis status:Complete
Number of Pages:115
Identification Number:
  • urn: urn:nbn:ch:bel-bau-diss148488
edoc DOI:
Last Modified:23 Nov 2022 05:30
Deposited On:22 Nov 2022 14:49

Repository Staff Only: item control page